JBT Marel reported third-quarter 2026 results with revenue down 1% to $994 million, while net income rose 6% to $70 million and diluted EPS reached $1.34. The Board also raised the total share repurchase authorization to $700 million, and the company revised its full-year 2026 revenue outlook to reflect lower near-term volume expectations.
Q3 revenue $994 million, down 1% from $1,001 million; net income $70 million, up 6%.
Diluted EPS $1.34 vs. $1.26 a year earlier; adjusted EPS $2.19 vs. $1.94.
Board authorized a $500 million increase on October 30, 2026, bringing the total repurchase authorization to $700 million; about 800,000 shares repurchased for $94 million in Q3.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From JBT Marel Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$3.80B
+121.3%
$-0.98
-137.0%
-1.3%
FY2024
$1.72B
+3.1%
$2.65
-85.4%
5.0%
FY2023
$1.66B
+4.7%
$18.13
+323.6%
35.0%
FY2022
$1.59B
+13.5%
$4.28
+15.4%
8.6%
FY2021
$1.40B
-18.9%
$3.71
+9.4%
8.5%
Frequently asked questions
When is JBT Marel's next earnings date?
JBT Marel has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did JBT Marel earn last quarter?
For the quarter ended Sep 2026, JBT Marel reported diluted EPS of $1.34 (+6.3% year over year) on revenue of $994.00M (-0.7%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.